Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Novartis

Status and phase: Completed; Phase 3

Conditions: Renal Transplantation

Treatments: Drug: FTY720

Study type: Interventional

Funder types: Industry

Identifiers

NCT00239876

CFTY720A2302E1

Details and patient eligibility

About

This study will evaluate the safety and efficacy of FTY720 combined with tacrolimus and corticosteroids in patients receiving a kidney transplant

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Completed the 12 month core study
• Informed consent Exclusion Criteria
• N/A Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)